CG Oncology · 1 week ago
Director, SOX Compliance
CG Oncology, Inc. is focused on advancing innovative oncology therapies and is seeking a Director of SOX Compliance to design, build, and lead their enterprise SOX 404 and internal controls program. This role involves architecting the SOX and controls foundation from the ground up while serving as a trusted advisor to executive leadership and the Audit Committee.
BiotechnologyHealth CareHealth DiagnosticsOncology
Responsibilities
Assess current processes and controls to establish a SOX readiness baseline and remediation roadmap
Design and document scalable business process controls and IT general controls
Lead risk-based SOX testing, evidence management, deficiency evaluation, and remediation
Oversee ITGCs including access, change management, and data integrity
Serve as the primary liaison with external auditors and advisors
Monitor regulatory and standards changes and translate them into practical policies and controls
Evaluate and integrate automation and AI-enabled tools to improve SOX efficiency and scalability over time
Qualification
Required
10+ years of progressive experience in SOX 404 compliance, internal controls, audit, or risk management, including leadership responsibility
Demonstrated experience building, implementing, or significantly scaling a SOX 404 program, ideally in a public company, pre-IPO, or high-growth environment
Strong working knowledge of COSO, GAAP, SEC, and PCAOB standards, with the ability to translate requirements into practical, business-aligned controls
Experience leading enterprise-wide control design, documentation, testing, and remediation, including coordination with external auditors
Proven ability to oversee IT General Controls (ITGCs) related to access, change management, and data integrity across financial systems
Track record of partnering effectively with senior leadership and Audit Committees, presenting complex issues clearly and confidently
Bachelor's degree in Accounting, Finance, Business, or a related field
Benefits
HIGHLY COMPETITIVE SALARIES
ANNUAL PERFORMANCE/MERIT REVIEWS
ANNUAL PERFORMANCE BONUSES
EQUITY
SPECIAL RECOGNITION
FULLY REMOTE WORK ENVIRONMENT
REST AND RECHARGE BENEFITS - Unlimited Flexible Time Off
HOLIDAYS –In 2025 we will observe 14 holidays
RETIREMENT – 401K with 100% company Safe Harbor match up to 4% of base salary
HEALTH (MEDICAL, DENTAL, VISION) – PPO & HDHP – Cigna/Principal
HEALTH SPENDING ACCOUNTS - HSA (with Annual Company Contribution), FSA, FSA-DC
ILLNESS & DISABILITY PROTECTION – Company Paid LTD Coverage + Voluntary Plans
LIFE INSURANCE – Company Paid 1 x base salary + Voluntary Plans
ADDITIONAL EXCLUSIVE BENEFITS – Voluntary Legal, Pet, Plus More
Company
CG Oncology
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
Funding
Current Stage
Public CompanyTotal Funding
$555.57MKey Investors
Kissei PharmaceuticalORI CapitalAlly Bridge Group
2024-12-12Post Ipo Equity· $238M
2024-01-25IPO
2023-08-02Series F· $105M
Recent News
Company data provided by crunchbase